ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 113 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,268,000 | -41.7% | 178,150 | -33.8% | 0.17% | -43.5% |
| Q2 2022 | $2,176,000 | -11.1% | 268,925 | +52.5% | 0.29% | -5.8% |
| Q1 2022 | $2,448,000 | +34.4% | 176,342 | +171.7% | 0.31% | +21.9% |
| Q4 2021 | $1,821,000 | +74.8% | 64,899 | +268.3% | 0.26% | +54.2% |
| Q4 2020 | $1,042,000 | -9.5% | 17,623 | -25.5% | 0.17% | -21.3% |
| Q3 2020 | $1,151,000 | +264.2% | 23,666 | +261.7% | 0.21% | +744.0% |
| Q2 2019 | $316,000 | – | 6,543 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |